SAVE Moms and Babies Act of 2021 Support And Value Expectant Moms and Babies Act of 2021 [S.78]
A bill to amend the Federal Food, Drug, and Cosmetic Act to prohibit the approval of new abortion drugs, to prohibit investigational use exemptions for abortion drugs, and to impose additional regulatory requirements with respect to previously approved abortion drugs, and for other purposes.
S.78: SAVE Moms and Babies Act of 2021 Support And Value Expectant Moms and Babies Act of 2021
Sponsored by: Sen. Mike Lee
Read Twice And Referred To The Committee On Health, Education, Labor, And Pensions. on 01/28/2021
Gabriella Miller Kids First Research Act 2.0 [HB-623]
To require certain civil penalties to be transferred to a fund through which amounts are made available for the Gabriella Miller Kids First Pediatric Research Program at the National Institutes of Health, and for other purposes.
HB-623: Gabriella Miller Kids First Research Act 2.0
Sponsored by: Rep. Gerald Connolly
Received In The Senate And Read Twice And Referred To The Committee On Health, Education, Labor, And Pensions. on 07/28/2022
HB-482: Newborn Screening Saves Lives Reauthorization Act of 2021
Sponsored by: Rep. Raul Grijalva
Received In The Senate And Read Twice And Referred To The Committee On Health, Education, Labor, And Pensions. on 06/24/2021
Securing America’s Medicine Cabinet Act of 2021 [HB-70]
To support the advanced manufacturing technologies program of the Food and Drug Administration, to establish National Centers of Excellence in Advanced Pharmaceutical Manufacturing, and for other purposes.
HB-70: Securing America’s Medicine Cabinet Act of 2021
Sponsored by: Rep. Vern Buchanan
Referred To The Subcommittee On Health. on 02/02/2021
Protecting Consumer Access to Generic Drugs Act of 2021 [HB-153]
To prohibit brand name drug manufacturers from compensating generic drug manufacturers to delay the entry of a generic drug into the market, and to prohibit biological product manufacturers from compensating biosimilar and interchangeable product manufacturers to delay entry of biosimilar and interchangeable products, and for other purposes.
HB-153: Protecting Consumer Access to Generic Drugs Act of 2021
Sponsored by: Rep. Gerald Connolly
Referred To The Subcommittee On Antitrust, Commercial, And Administrative Law. on 03/04/2021